Parnax Lab

Pharmaceuticals & Drugs
₹109.95
-6.03%
Prev close ₹117
Get AI-Powered Analysis for Parnax Lab Free Analysis → FREE View live price, charts & full analysis for Parnax Lab →

Parnax Lab Share Price Chart

Parnax Lab last traded at ₹109.95 (2026-10-13). Over the past month the stock moved -17.6%, three months the stock moved -25.7%, year the stock moved -15.3%. Its closing range over 52 weeks is ₹109.95 – ₹163.85, with the latest close 32.9% below the high.

Closing prices up to 2026-10-13.

About Parnax Lab

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

Business Overview:[1][2] PLL is a part Naxpar Group and is a WHO-approved and EHS-compliant Company. It is into contract manufacturing of Liquid Orals, Capsules, Ointments, External Powders & Tablets with its manufacturing facility located at Silvassa.

Fundamentals

Market Cap₹134.50 Cr
52W High₹182
52W Low₹99.20
P/E Ratio15.05
P/B Ratio1.41
EPS₹7.78
Dividend Yield0%
ROE (3yr)15%
Sales Growth (3yr)14%
Profit Growth (3yr)14%

Quarterly Results

In the latest quarter (Jun 2026), Parnax Lab reported sales of ₹56.80 crore (+6.4%) and net profit of ₹0.43 crore (-86.9%), compared with the same quarter last year.

Parnax Lab quarterly results (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Jun 202656.804.317.590.430.37
Mar 202669.634.887.012.191.90
Dec 202562.946.8510.882.712.36
Sep 202562.608.0812.913.623.16
Jun 202553.387.4413.943.282.85
Mar 202549.046.6313.522.932.54
Dec 202440.224.2710.621.211.05
Sep 202448.367.2414.973.422.97
Year-on-year change vs the same quarter last year
Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales growth+13.5%-21.1%+5.8%+6.5%+29.4%+56.5%+42.0%+6.4%
Operating profit growth+36.9%-28.5%+14.5%-13.7%+11.6%+60.4%-26.4%-42.1%
Net profit growth+82.9%-44.5%+30.8%-17.8%+5.8%+124.0%-25.3%-86.9%
EPS growth+82.2%-44.7%+30.3%-17.9%+6.4%+124.8%-25.2%-87.0%
OPM %15.0%10.6%13.5%13.9%12.9%10.9%7.0%7.6%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Annual Financials

In the latest year (Mar 2026), Parnax Lab reported sales of ₹249.00 crore (+32.4%) and net profit of ₹12.00 crore (+0.0%), compared with the previous year.

Parnax Lab annual profit & loss (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 2026249.0027.0011.0012.0010.26
Mar 2025188.0027.0014.0012.0010.03
Mar 2024189.0024.0012.0010.008.37
Mar 2023168.0023.0014.009.007.51
Mar 2022163.0023.0014.008.008.40
Mar 202190.0010.0011.000.00-0.42
Mar 202095.006.007.00-3.00-3.42
Mar 2019109.0010.009.003.003.88
Year-on-year change vs the previous year
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales growth+2.8%-12.8%-5.3%+81.1%+3.1%+12.5%-0.5%+32.4%
Operating profit growth+0.0%-40.0%+66.7%+130.0%+0.0%+4.3%+12.5%+0.0%
Net profit growth+200.0%-200.0%––+12.5%+11.1%+20.0%+0.0%
EPS growth+215.4%-188.1%––-10.6%+11.5%+19.8%+2.3%
OPM %9.0%7.0%11.0%14.0%14.0%12.0%14.0%11.0%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Shareholding

Promoter Holding72.30%

AI Analysis

No AI analysis generated yet for Parnax Lab.

Get Free AI Stock Analysis FREE →

Latest News

No recent news available for Parnax Lab.

Frequently Asked Questions

What is the share price of Parnax Lab today?

Parnax Lab shares were last quoted at ₹109.95 (-6.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.

What is the P/E ratio of Parnax Lab?

Parnax Lab has a price-to-earnings (P/E) ratio of 15.05 and a price-to-book (P/B) ratio of 1.41. The industry P/E is 53.33.

What is the 52-week high and low of Parnax Lab?

The 52-week high of Parnax Lab is ₹182.00 and the 52-week low is ₹99.20.

What is the market cap of Parnax Lab?

The market capitalisation of Parnax Lab is about ₹134.50 crore.

How did Parnax Lab perform in its latest quarterly results?

In the latest quarter (Jun 2026), Parnax Lab reported sales of ₹56.80 crore (+6.4%) and net profit of ₹0.43 crore (-86.9%), compared with the same quarter last year.

Is Parnax Lab a good stock to buy?

This page is for information and is not investment advice. As per the data shown here, Parnax Lab has a 3-year ROE of 15.00%, 3-year profit growth of 14.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.

What is the promoter holding in Parnax Lab?

Promoters hold about 72.30% of Parnax Lab.

Which sector does Parnax Lab belong to?

Parnax Lab belongs to the Pharmaceuticals & Drugs sector.

Other Pharmaceuticals & Drugs stocks

All Pharmaceuticals & Drugs stocks · Browse all stocks A–Z

Go to live page for Parnax Lab →